U
Unicycive Therapeutics D
D
UNCY
6.31000
USD
5.65
(851.45%)
مغلق
حجم التداول
134,656
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
761,170,763
العنوان: Unicycive Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent beingdeveloped for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.